Characterization of specific antibodies against cytomegalovirus (CMV)-encoded interleukin 10 produced by 28% of CMV-seropositive blood donors

Journal of General Virology

Volumn 92, Issue 7, 2011, Pages 1508-1518

  Rieper, Carina de Lemos ^a,b   Galle, Pia ^b   Pedersen, Bente Klarlund ^b   Hansen, Morten Bagge ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; JANUS KINASE; STAT PROTEIN;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; BLOOD DONOR; CONTROLLED STUDY; CROSS REACTION; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VIRUS CHARACTERIZATION;

ANTIBODIES, VIRAL; BLOOD DONORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INTERLEUKIN-10; MALE; VIRAL PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4;

EID: 79959287296     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.028738-0     Document Type: Article

References (40)

1. Bego, M. G. & St Jeor, S. (2006). Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency. Exp Hematol 34, 555-570.
2. Bendtzen, K., Hansen, M. B., Ross, C. & Svenson, M. (2000). Detection of autoantibodies to cytokines. Mol Biotechnol 14, 251-261.
3. Cheung, T. W. & Teich, S. A. (1999). Cytomegalovirus infection in patients with HIV infection. Mt Sinai J Med 66, 113-124.
4. Couper, K. N., Blount, D. G. & Riley, E. M. (2008). IL-10: the master regulator of immunity to infection. J Immunol 180, 5771-5777.
5. Crough, T. & Khanna, R. (2009). Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22, 76-98.
6. de Lemos Rieper, C., Galle, P. & Hansen, M. B. (2009a). Characterization and potential clinical applications of autoantibodies against cytokines. Cytokine Growth Factor Rev 20, 61-75.
7. de Lemos Rieper, C., Galle, P., Svenson, M., Pedersen, B. K. & Hansen, M. B. (2009b). Preparation and validation of radio iodinated recombinant human IL-10 for the measurement of natural human antibodies against IL-10. J Immunol Methods 350, 46-53.
8. de Lemos Rieper, C., Galle, P., Pedersen, B. K. & Hansen, M. B. (2010). A state of acquired IL-10 deficiency in 0.4% of Danish blood donors. Cytokine 51, 286-293.
9. deWaal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H. & de Vries, J. E. (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174, 915-924.
10. Drew W. L. (1988). Diagnosis of cytomegalovirus infection. Rev Infect Dis 10 (Suppl 3), S468-S476.
11. Falagas, M. E., Snydman, D. R., Ruthazer, R., Griffith, J., Werner, B. G., Freeman, R. & Rohrer, R. (1997). Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group. Clin Transplant 11, 432-437.
12. Finlay, B. B. & McFadden, G. (2006). Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124, 767-782.
13. Griffiths, P. D. & Walter, S. (2005). Cytomegalovirus. Curr Opin Infect Dis 18, 241-245.
14. Hansen, M. B., Svenson, M., Abell, K., Yasukawa, K., Diamant, M. & Bendtzen, K. (1995). Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors. Eur J Immunol 25, 348-354.
15. Hislop, A. D., Taylor, G. S., Sauce, D. & Rickinson, A. B. (2007). Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25, 587-617.
16. Jenkins, C., Abendroth, A. & Slobedman, B. (2004). A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78, 1440-1447.
17. Jenkins, C., Garcia, W., Abendroth, A. & Slobedman, B. (2008). Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology 370, 285-294.
18. Jones, B. C., Logsdon, N. J., Josephson, K., Cook, J., Barry, P. A. & Walter, M. R. (2002). Crystal structure of human cytomegalovirus IL- 10 bound to soluble human IL-10R1. Proc Natl Acad Sci U S A 99, 9404-9409.
19. Kanegane, H., Wakiguchi, H., Kanegane, C., Kurashige, T. & Tosato, G. (1997). Viral interleukin-10 in chronic active Epstein-Barr virus infection. J Infect Dis 176, 254-257.
20. Kano, Y. & Shiohara, T. (2000). Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci 22, 196-204.
21. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V. & Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 97, 1695-1700.
22. Lehner, P. J. & Wilkinson, G. W. (2001). Cytomegalovirus: from evasion to suppression? Nat Immunol 2, 993-994.
23. Limaye, A. P., Raghu, G., Koelle, D. M., Ferrenberg, J., Huang, M. L. & Boeckh, M. (2002). High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 185, 20-27.
24. Lin, Y. L., Chang, P. C., Wang, Y. & Li, M. (2008). Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. Virus Res 131, 213-223.
25. Lockridge, K. M., Zhou, S. S., Kravitz, R. H., Johnson, J. L., Sawai, E. T., Blewett, E. L. & Barry, P. A. (2000). Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268, 272-280.
26. Menetrier-Caux, C., Briere, F., Jouvenne, P., Peyron, E., Peyron, F. & Banchereau, J. (1996). Identification of human IgG autoantibodies specific for IL-10. Clin Exp Immunol 104, 173-179.
27. Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A. & Mosmann, T. R. (1990). Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248, 1230-1234.
28. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765.
29. Nigro, G., Adler, S. P., La Torre, R., Best, A. M. &Congenital Cytomegalovirus Collaborating Group (2005). Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353, 1350-1362.
30. Rowshani, A. T., Bemelman, F. J., van Leeuwen, E. M., van Lier, R. A. & ten Berge, I. J. (2005). Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 79, 381-386.
31. Salek-Ardakani, S., Arrand, J. R. & Mackett, M. (2002). Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 304, 342-351.
32. Sinclair, J. (2008). Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J Clin Virol 41, 180-185.
33. Slobedman, B., Barry, P. A., Spencer, J. V., Avdic, S. & Abendroth, A. (2009). Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 83, 9618-9629.
34. Snydman, D. R., Werner, B. G., Heinze-Lacey, B., Berardi, V. P., Tilney, N. L., Kirkman, R. L., Milford, E. L., Cho, S. I., Bush, H. L., Jr & other authors (1987). Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 317, 1049-1054.
35. Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. & Schall, T. J. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76, 1285-1292.
36. Spencer, J. V., Cadaoas, J., Castillo, P. R., Saini, V. & Slobedman, B. (2008). Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL- 10. Virology 374, 164-169.
37. Tanner, J. E., Diaz-Mitoma, F., Rooney, C. M. & Alfieri, C. (1997). Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection. J Infect Dis 176, 1454-1461.
38. Vancíková, Z. & Dvorá k, P. (2001). Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review. Curr Drug Targets Immune Endocr Metabol Disord 1, 179-187.
39. Yoon, S. I., Jones, B. C., Logsdon, N. J. & Walter, M. R. (2005). Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain. Structure 13, 551-564.
40. Zdanov, A. (2004). Structural features of the interleukin-10 family of cytokines. Curr Pharm Des 10, 3873-3884.